Fensolvi Injection, Suspension, Extended Release
Product Images NDC 62935-163

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 23 technical images submitted to the FDA as part of the official labeling for Fensolvi (NDC 62935-163). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tolmar Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Admin (Fensolvi Pss 1)

Admin (Fensolvi Pss 1)
An instructional diagram showing the components of the Fensolvi injection kit. The left section labeled 'Tray Contents' displays Syringe A and Syringe B connected by a coupling device with a latching button. The right section labeled 'Under the Tray' illustrates the safety needle and cap, highlighting the needle hub, safety shield, and cap.*
FDA Label Image

Step7 (Fensolvi Pss 10)

Step7 (Fensolvi Pss 10)
An instructional diagram showing two hand positions for activating the device, each accompanied by the word "Click" and directional arrows indicating the motion needed to achieve the "Click" action.*
FDA Label Image

Structure (Fensolvi Pss 11)

Structure (Fensolvi Pss 11)
Chemical structure of Leuprolide Acetate, the active ingredient in Fensolvi 45 mg/.375mL injection suspension, extended release. The diagram illustrates the molecular arrangement of atoms and bonds in the compound.*
FDA Label Image

Mixing (Fensolvi Pss 12)

Mixing (Fensolvi Pss 12)
An instructional diagram showing tray contents for Fensolvi (Leuprolide Acetate) injection. It illustrates two syringes labeled Syringe A and Syringe B connected by a coupling device with a latching button, as well as a safety needle and cap with parts labeled safety shield, needle hub, and cap.*
FDA Label Image

Step2 (Fensolvi Pss 13)

Step2 (Fensolvi Pss 13)
An instructional diagram showing two syringes labeled Syringe A and Syringe B being connected using a coupling device with a latching button. The image highlights the mechanism for attaching the syringes together, with arrows indicating the points of interaction.*
FDA Label Image

Step3 (Fensolvi Pss 14)

Step3 (Fensolvi Pss 14)
Illustration showing the operation of a syringe-style injector with instructions to 'Push A' forward, then 'Push B' backward, completing one cycle. The process is to be repeated 60 times, demonstrating the mechanism for mixing or activating the medication before use.*
FDA Label Image

Step4 (Fensolvi Pss 15)

Step4 (Fensolvi Pss 15)
An instructional illustration showing the connection of two syringes labeled Syringe A and Syringe B. A hand holds Syringe B steady while another hand presses Syringe A downward to engage with Syringe B, indicating a preparatory step for medication administration.*
FDA Label Image

Step5 (Fensolvi Pss 16)

Step5 (Fensolvi Pss 16)
An instructional diagram showing two syringes labeled Syringe A and Syringe B. It depicts the process of connecting Syringe A above Syringe B with an arrow indicating upward movement and a twisting motion for joining the two syringes.*
FDA Label Image

Step6 (Fensolvi Pss 17)

Step6 (Fensolvi Pss 17)
An instructional illustration showing a gloved hand pressing down on the plunger of Syringe B, which is held by another hand. The image appears to demonstrate a step in the preparation or administration of a medication using a syringe.*
FDA Label Image

Step7 (Fensolvi Pss 18)

Step7 (Fensolvi Pss 18)
An instructional diagram depicting a hand holding a syringe labeled 'Syringe B' being pulled upward from a vial or container. This illustration likely demonstrates part of the preparation or administration process for an injection.*
FDA Label Image

Admin (Fensolvi Pss 19)

Admin (Fensolvi Pss 19)
An instructional illustration showing a hand pinching the skin on a person's arm, demonstrating the proper technique for subcutaneous injection administration.*
FDA Label Image

Step2 (Fensolvi Pss 2)

Step2 (Fensolvi Pss 2)
An instructional diagram showing two syringes labeled Syringe A and Syringe B connected by a coupling device with a latching button. The illustration demonstrates how to attach the syringes using the coupling mechanism with directional arrows indicating motion.*
FDA Label Image

Admin (Fensolvi Pss 20)

Admin (Fensolvi Pss 20)
An instructional illustration showing a hand administering a subcutaneous injection at a 90-degree angle into the skin. The image emphasizes proper injection technique, likely related to the use of Fensolvi (Leuprolide Acetate) extended-release suspension.*
FDA Label Image

Step7 (Fensolvi Pss 21)

Step7 (Fensolvi Pss 21)
An instructional illustration showing hand positions for activating a mechanism with a 'click.' One side depicts holding and pulling a tab on an angled device, while the other shows pressing a button or cap on top. Both demonstrate the action to produce a 'click' sound for device activation.*
FDA Label Image

Carton (Fensolvi Pss 22)

Carton (Fensolvi Pss 22)
Fensolvi 45 mg extended-release injection, suspension for subcutaneous use, displayed as a full carton label. The label includes dosing frequency of every 6 months, NDC 62935-163-60, and indicates it is a single-dose product supplied by TOLMAR Inc. Additional details mention it must be reconstituted before use and administered by a healthcare provider.*
FDA Label Image

Carton (Fensolvi Pss 23)

Carton (Fensolvi Pss 23)
Fensolvi Leuprolide Acetate injection, suspension, extended release packaging label section showing instructions to see full guide inside for preparation, mixing, and administration. Includes a QR code linking to Fensolvi Instructions for Use. Label features orange and white background panels.*
FDA Label Image

Step3 (Fensolvi Pss 3)

Step3 (Fensolvi Pss 3)
An instructional diagram showing two syringes with labeled actions 'Push A' and 'Push B' indicating directional steps. Below the syringes is a circular arrow graphic denoting '1 cycle' with a note to 'Repeat 60x,' illustrating a repeated push cycle procedure.*
FDA Label Image

Step4 (Fensolvi Pss 4)

Step4 (Fensolvi Pss 4)
An instructional illustration showing two syringes labeled Syringe A and Syringe B being connected. A hand is pushing Syringe A down into Syringe B, indicating a step in the preparation or administration process of the medication.*
FDA Label Image

Step5 (Fensolvi Pss 5)

Step5 (Fensolvi Pss 5)
An instructional diagram showing how to connect two syringes labeled Syringe A and Syringe B. The image depicts hand positioning and rotational motion to assemble Syringe A onto Syringe B, likely for drug preparation or administration.*
FDA Label Image

Step6 (Fensolvi Pss 6)

Step6 (Fensolvi Pss 6)
An instructional illustration showing a hand holding a syringe labeled 'Syringe B' and pushing down on its plunger. It depicts a step in handling or preparing the syringe, likely related to the administration of a medication injection.*
FDA Label Image

Step7 (Fensolvi Pss 7)

Step7 (Fensolvi Pss 7)
An instructional illustration showing a gloved hand holding a syringe labeled as 'Syringe B' being pulled straight up off a vial or container, indicating the removal of the syringe from the vial as part of the injection preparation process.*
FDA Label Image

Admin (Fensolvi Pss 8)

Admin (Fensolvi Pss 8)
An instructional illustration showing a hand pinching the skin of a forearm, likely depicting a technique for administering a subcutaneous injection.*
FDA Label Image

Admin (Fensolvi Pss 9)

Admin (Fensolvi Pss 9)
An instructional illustration showing the method of administering a subcutaneous injection using a syringe. The syringe is held at a 90-degree angle to the skin surface, with the needle inserted into the patient's skin fold. The image demonstrates proper injection technique for subcutaneous delivery.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.